Caldwell Trust
ABBV icon

Caldwell Trust’s AbbVie ABBV Stock Holding History

Caldwell Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7M Sell
26,771
-299
-1% -$76.7K 0.55% 47
2026
Q2 		$6.81M Buy
27,070
+1,557
+6% +$335K 0.55% 46
2026
Q1 		$5.55M Buy
25,513
+1,064
+4% +$236K 0.5% 50
2025
Q4 		$5.59M Sell
24,449
-540
-2% -$123K 0.5% 51
2025
Q3 		$5.79M Sell
24,989
-121
-0.5% -$24.6K 0.54% 46
2025
Q2 		$4.66M Buy
25,110
+759
+3% +$141K 0.47% 51
2025
Q1 		$5.1M Buy
24,351
+244
+1% +$47.4K 0.55% 42
2024
Q4 		$4.28M Sell
24,107
-1,356
-5% -$249K 0.45% 52
2024
Q3 		$5.03M Buy
25,463
+538
+2% +$100K 0.53% 44
2024
Q2 		$4.28M Sell
24,925
-487
-2% -$80.7K 0.47% 47
2024
Q1 		$4.63M Sell
25,412
-334
-1% -$57.6K 0.54% 45
2023
Q4 		$3.99M Sell
25,746
-3,033
-11% -$442K 0.5% 49
2023
Q3 		$4.29M Sell
28,779
-2,699
-9% -$396K 0.59% 44
2023
Q2 		$4.24M Buy
31,478
+145
+0.5% +$21.3K 0.55% 45
2023
Q1 		$4.99M Sell
31,333
-170
-0.5% -$26K 0.69% 39
2022
Q4 		$5.09M Sell
31,503
-1,975
-6% -$303K 0.72% 40
2022
Q3 		$4.49M Sell
33,478
-967
-3% -$139K 0.67% 41
2022
Q2 		$5.28M Sell
34,445
-278
-0.8% -$42.5K 0.73% 39
2022
Q1 		$5.63M Sell
34,723
-74
-0.2% -$10.7K 0.67% 39
2021
Q4 		$4.71M Sell
34,797
-232
-0.7% -$27.4K 0.54% 45
2021
Q3 		$3.78M Buy
35,029
+1,350
+4% +$154K 0.48% 50
2021
Q2 		$3.79M Sell
33,679
-208
-0.6% -$23.4K 0.5% 48
2021
Q1 		$3.67M Buy
33,887
+299
+0.9% +$32K 0.51% 47
2020
Q4 		$3.6M Buy
33,588
+575
+2% +$55.3K 0.54% 46
2020
Q3 		$2.89M Sell
33,013
-864
-3% -$81.3K 0.48% 52
2020
Q2 		$3.33M Buy
33,877
+511
+2% +$45K 0.56% 51
2020
Q1 		$2.54M Sell
33,366
-2,412
-7% -$205K 0.48% 56
2019
Q4 		$3.17M Buy
+35,778
New +$2.97M 0.48% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Caldwell Trust's ABBV Position: Q3 2026 in Review

Caldwell Trust reduced its AbbVie (ABBV) stake by 1.1% in Q3 2026, selling an estimated $76.7K and leaving 26,771 shares worth $7M. The position accounts for 0.55% of the portfolio, ranked #47.

Caldwell Trust first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Caldwell Trust held 26,771 shares of AbbVie worth $7M as of Q3 2026.
  • Caldwell Trust sold 299 AbbVie shares in Q3 2026, an estimated $76.7K.
  • AbbVie made up 0.55% of Caldwell Trust's portfolio in Q3 2026, its #47 holding.
  • Caldwell Trust first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.